DI
MYGN icon

DAGCO Inc’s Myriad Genetics MYGN Stock Holding History

DAGCO Inc’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-276
Closed -$5.28K – 331
2023
Q4 		$5.28K Buy
+276
New +$4.78K ﹤0.01% 227

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DAGCO Inc's MYGN Position: Q1 2024 in Review

DAGCO Inc sold out of Myriad Genetics (MYGN) in Q1 2024, closing a stake of 276 shares — an estimated $5.28K sold.

DAGCO Inc first reported a position in MYGN in Q4 2023 and held it in 1 quarter. The position peaked at $5.28K in Q4 2023. 186 funds tracked by Wall St. Rank hold MYGN as of Q1 2024.

  • DAGCO Inc reported no remaining Myriad Genetics position as of Q1 2024 after selling out during the quarter.
  • DAGCO Inc sold 276 Myriad Genetics shares in Q1 2024, an estimated $5.28K.
  • DAGCO Inc first reported a position in Myriad Genetics in Q4 2023 and held it in 1 quarter.
  • DAGCO Inc's Myriad Genetics position peaked at $5.28K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2024.

Based on DAGCO Inc's 13F filing for Q1 2024, filed 15 May 2024.